Shades for Migraine Partners with Rising Influencers to Empower People with Migraine
May 25, 2021 09:03 ET
|
Association of Migraine Disorders
Rhode Island, May 25, 2021 (GLOBE NEWSWIRE) -- Providence, R.I. (May 25, 2021) – Global awareness campaign, Shades for Migraine®, teams up with two rising social media influencers, YouTuber,...
Qualigen Therapeutics, Inc. Promotes Shishir Sinha to Chief Operating Officer Position
March 09, 2021 08:30 ET
|
Qualigen Therapeutics, Inc.
CARLSBAD, Calif., March 09, 2021 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a biotechnology company focused on developing novel therapeutics for the treatment of cancer and...
Connectyx Announces Grant of License from National Institutes of Health for Use of Novel Monoclonal Antibody to Treat Glioblastoma
October 16, 2020 11:00 ET
|
Connectyx Technologies Holdings Group, Inc
Boca Raton, FL, Oct. 16, 2020 (GLOBE NEWSWIRE) -- Connectyx Technologies Holdings Group, Inc. (OTC: CTYX) (“Connectyx” or the “Company”), a development-stage biomedical company focusing on novel...
CYTOVIA Therapeutics and MACROMOLTEK to Develop Dual-Acting Natural Killer Immunotherapy Against SARS CoV2 (COVID-19)
April 07, 2020 09:03 ET
|
Cytovia Therapeutics
NEW YORK and AUSTIN, Texas, April 07, 2020 (GLOBE NEWSWIRE) -- Cytovia Therapeutics (“Cytovia”), an emerging biopharmaceutical company developing Natural Killer (NK) immunotherapies for cancer and...
Natural Health Farm Holdings, Inc. and BioDelta Terminate Acquisition Agreement
May 14, 2019 19:43 ET
|
NATURAL HEALTH FARM HOLDINGS INC
Vegas, Nevada, May 14, 2019 (GLOBE NEWSWIRE) -- Natural Health Farm Holdings, Inc (OTCQB: NHEL) (the “Company” or “NHF Holdings”), a nutraceutical biotechnology company, reports that the previously...
Ritter Pharmaceuticals Reports Year End 2018 Financial Results and Provides Business Update
March 29, 2019 09:00 ET
|
Ritter Pharmaceuticals, Inc.
LOS ANGELES, March 29, 2019 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals” or the “Company”), a developer of therapeutic products that modulate the gut...
Ritter Pharmaceuticals Completes Enrollment in Pivotal Phase 3 Clinical Trial of RP-G28 in Patients with Lactose Intolerance
March 05, 2019 08:30 ET
|
Ritter Pharmaceuticals, Inc.
Top-line Data Readout Expected in early Q4 2019 LOS ANGELES, March 05, 2019 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals” or the “Company”), a...
Midatech Pharma US enrols first patient in Gelclair trial in stem cell transplant
June 08, 2018 02:00 ET
|
Midatech Pharma Plc
8 June 2018 Midatech Pharma PLC(“Midatech”, “Company” or “Group”) Midatech Pharma US enrols first patient in Gelclair® trial in stem cell transplant Patients now being enrolled at the...
Predictive Technology Group Appoints Dr. Gregory A. Prince to Its Scientific Advisory Board
January 17, 2018 09:20 ET
|
PREDICTIVE TECHNOLOGY GROUP, INC.
SALT LAKE CITY, Jan. 17, 2018 (GLOBE NEWSWIRE) --
Predictive Technology Group, Inc. (OTC PINK:PRED), a leader in the use of data analytics for disease identification and subsequent...
Predictive Technology Group (PRED) Appoints John C. Nelson, M.D., M.P.H. to the Predictive Technology Group Scientific Advisory Board
January 11, 2018 09:30 ET
|
PREDICTIVE TECHNOLOGY GROUP, INC.
SALT LAKE CITY, Jan. 11, 2018 (GLOBE NEWSWIRE) -- Predictive Technology Group, Inc. (OTCPINK:PRED) announces that Dr. John C. Nelson, M.D., M.P.H. will join the Predictive Technology Group...